Scienture Holdings, Inc. Common Stock
Here’s whether Scienture Holdings, Inc. Common Stock (SCNX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.62% over 10 days); 3-month momentum positive (+13.9%). Concerns: trading below the 200-day MA (long-term downtrend); RSI 74 — overbought, elevated pullback risk; weak 1-year return of -62.1%; rising volume on a downtrend (distribution, 1.36x avg). Currently 82.3% off its 52-week high. Score: -1/7.
SCNX is trading below its 200-day MA ($0.46) — a key warning sign the longer-term trend is under pressure. With an RSI of 74.2, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -62.1% compares to +20.4% for SPY (trailed the market by 82.4%). The current 82.3% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.